Millcreek Outcomes Group LLC
PO Box 58401
Salt Lake City, UT 84158
Phone: +1 801 244-8363
Diana Brixner, Ph.D., R.Ph.
Joseph Biskupiak, Ph.D., M.B.A.
Gary Oderda, Pharm.D., M.P.H.
Diana Brixner is a principal of the Millcreek Outcomes Group, Professor and Chair of the Department of Pharmacotherapy at the University of Utah College of Pharmacy and serves as Executive Director of the Pharmacotherapy Outcomes Research Center. Prior to moving to Utah, she spent 15 years in the pharmaceutical industry in outcomes research and managed care, including a position as Vice President of Health Care Management at Novartis Pharmaceuticals Corporation where she designed and conducted outcomes research to support the positioning of pharmaceutical products in the marketplace and to assure formulary acceptance in managed markets. She earned her undergraduate degree in pharmacy in 1982 from the University of Rhode Island and her doctorate in medicinal chemistry in 1987 from the University of Utah. Dr. Brixner has published numerous articles in peer-reviewed journals and 3 book chapters in the arena of outcomes research, holds 1 issued patent, and has been an invited speaker at a variety of national and international professional meetings. She is a past president for the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and has recently completed a 2-year term on the AMCP Board of Directors.
Dr. Joseph Biskupiak is Research Associate Professor in the Department of Pharmacotherapy and Director of the Outcomes Research Center at the College of Pharmacy, University of Utah in Salt Lake City, Utah. Dr. Biskupiak’s research interests include health economics, disease management and the U.S. health care system. Dr. Biskupiak is a member of the editorial board for P&T (a peer-reviewed journal for managed care- and hospital-formulary management).
Prior to joining the University of Utah, Dr. Biskupiak was a Director for Strategyx, a pharmaceutical consulting company located in Somerville, New Jersey. Prior to joining Strategyx, Dr. Biskupiak was Vice President of Health Services Research at Hastings Healthcare Group, Pennington, New Jersey. In addition, he was a research assistant professor conducting health economics research in the Office of Health Policy and Clinical Outcomes at Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. He was also a research scientist and research assistant professor in the Department of Radiology at the University of Washington School of Medicine in Seattle, involved in the development of imaging agents for positron emission tomography (PET) and a research investigator in the new drug discovery group at E. R. Squibb and Sons. Dr. Biskupiak has published widely, particularly in the basic and applied sciences and health services research field. He contributed the chapters “Disease Management Programs” in the textbook The Role of Pharmacoeconomics in Outcomes Management and “Managed Care Models of Disease Management” in Disease Management: A Systems Approach to Improving Patient Outcomes, both 1996 publications of AHA Press. He has also written chapters on health assessment tools and changing patient behavior. He earned a PhD degree in medicinal chemistry from the University of Utah, an MBA from Seattle University, and a BS in chemistry from the University of Connecticut.
Dr. Gary Oderda is Professor and Director of the Pharmacotherapy Outcomes Research Center at the University of Utah College of Pharmacy in Salt Lake City, Utah. Dr. Oderda received his Pharm.D. degree from the University of California at San Francisco in 1972 and completed an internship and residency in Clinical Pharmacy at the University of California Hospital in 1973. He received a Masters in Public Health in 1982 at the Johns Hopkins University School of Hygiene and Public Health. Following 18 years at the University of Maryland where he served as a Professor and Director of the Maryland Poison Center, he moved to the University of Utah where he served as Professor and Chairman of the Department of Pharmacy Practice. In 1999, Dr. Oderda was a Visiting Professor in the Department of Health Care Management at Novartis Pharmaceuticals Corporation in East Hanover, New Jersey. He was active in a variety of Outcomes Research and Disease Management projects. He returned to the University of Utah where he currently is a Professor and a Director of the University of Utah Pharmacotherapy Outcomes Research Center.